ArticleHematology reports2015

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.

Monica Carpenedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.